Governor, legislators look to raise awareness for Tardive Dyskinesia

John Snyder, Melanie Brown-Woofter, Ana Maria Rodriguez,
The movement disorder can be caused by antipsychotics used to treat certain mental health conditions.

Gov. Ron DeSantis and state lawmakers are seeking to highlight Tardive Dyskinesia (TD) Awareness Week, beginning Sunday.

The Governor has signed a proclamation supporting TD Awareness Week, which runs from May 2-8. Republican Sen. Ana Maria Rodriguez and GOP Rep. John Snyder also recently joined Florida Behavioral Health Association (FBHA) President and CEO Melanie Brown-Woofter to highlight measures from the Senate and House aiming to bring attention to those suffering from TD.

The condition is described as “an involuntary, sometimes irreversible movement disorder that can occur due to use of antipsychotics, commonly prescribed to treat bipolar disorder, schizophrenia, and depression, or other medications,” according to an explainer from the Movement Disorders Policy Coalition.

Those medications work as dopamine receptor blocking agents (DRBAs) and can help treat those serious mental health conditions. But some patients also develop TD as a side effect — even long after they’ve ceased taking those medications.

Estimates show that more than half a million Americans suffer from TD. The National Alliance for Mental Illness pegs that number as around one-fourth of all patients who receive long-term treatment with antipsychotic medication.

Brown-Woofter’s group joined with Rodriguez and Snyder, who each sponsored respective measures during this year’s Legislative Session recognizing May 2-8 as TD Awareness Week (SR 2014, HR 8043).

“I am so honored to join Florida’s mental health community in recognizing TD Awareness Week during the first full week of May,” Brown-Woofter said.

“It is so important that we continue to raise awareness around this involuntary movement disorder, which significantly impacts people physically, emotionally and socially, and continue to educate our citizens about mental health.”

DRBAs can also be used to treat certain gastrointestinal disorders, such as gastroparesis and nausea. The Legislature’s resolutions not that alcoholism combined with the used of DRBAs can increase the chances of developing TD. Postmenopausal women and people with mood disorders also are at higher risk of developing TD.

The FDA recently approved two new treatments for TD, though patients taking these medications must be screened for potential TD symptoms.

Ryan Nicol

Ryan Nicol covers news out of South Florida for Florida Politics. Ryan is a native Floridian who attended undergrad at Nova Southeastern University before moving on to law school at Florida State. After graduating with a law degree he moved into the news industry, working in TV News as a writer and producer, along with some freelance writing work. If you'd like to contact him, send an email to [email protected]


Florida Politics is a statewide, new media platform covering campaigns, elections, government, policy, and lobbying in Florida. This platform and all of its content are owned by Extensive Enterprises Media.

Publisher: Peter Schorsch

Contributors & reporters: Phil Ammann, Jason Delgado, Renzo Downey, Rick Flagg, A.G. Gancarski, Anne Geggis, Joe Henderson, Janelle Irwin, Ryan Nicol, Jacob Ogles, Jesse Scheckner, Scott Powers, Andrew Wilson, and Kelly Hayes.

Email: [email protected]
Twitter: @PeterSchorschFL
Phone: (727) 642-3162
Address: 204 37th Avenue North #182
St. Petersburg, Florida 33704

Sign up for Sunburn